10 results
Insulin and analogues onset of action, peak times and duration.

Follow at www.instagram.com/rxnotes for more!

#pharmacology #table #comparison
Insulin and analogues ... peak times and duration ... #pharmacology #table ... #diabetes #medications ... halflife #onset #duration
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Insulin Lifestyle ... Sulfonylureas GLP ... #medications #table ... endocrinology #dm2
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
DPP-4 inhibitor, GLP ... requirements are ... #Mellitus #DM2 ... #pharmacology # ... comparison #table
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
commonly used medications ... to treat Type 2 Diabetes ... for insulin. ... #Pharmacology #Dosing ... #Diabetes #DM2
Oral Hypoglycemics in Diabetes Management
1  INSULIN SENSITIZER
 • TZD 
     -
) 3 CARB ABSORPTION ... INCRETIN AGENTS • GLP ... - Prevents GLP ... #Management #pharmacology ... #DM2 #DMII #Classification
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
- Pharmacology ... glucose-dependent insulin ... Ozempic), or daily tablet ... #Summary #DM2 # ... diabetes #endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Increase Incretins (GLP-I ... -> Stimulates Insulin ... Renal #Dosing #Pharmacology ... #Management #Diabetes ... #DM2 #Endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
semaglutide, the same medication ... drug to remain stable ... GLP1 agonists are ... #semaglutide #Diabetes ... #Pharmacology #
Long-Acting Injectable (LAI) - Atypical Antipsychotics 
INVEGA TRINZA 3 MONTHS 
ARISTADA 2 MONTHS 
INVEGA 1 MONTH
SUSTENNA
Adherence to daily medications ... Pharmacists are ... able to administer ... Antipsychotics #Pharmacology ... #Duration #Psychiatry
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
- Allergies to medications ... Insulin dependent ... DM ACS NSQIP: ... ACEi/ARBs - Hold ... Diabetes regimen